Joseph Rager

462 total citations
9 papers, 339 citations indexed

About

Joseph Rager is a scholar working on Molecular Biology, Small Animals and Pathology and Forensic Medicine. According to data from OpenAlex, Joseph Rager has authored 9 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 1 paper in Small Animals and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Joseph Rager's work include Cancer-related gene regulation (4 papers), Cancer Mechanisms and Therapy (1 paper) and CRISPR and Genetic Engineering (1 paper). Joseph Rager is often cited by papers focused on Cancer-related gene regulation (4 papers), Cancer Mechanisms and Therapy (1 paper) and CRISPR and Genetic Engineering (1 paper). Joseph Rager collaborates with scholars based in United States. Joseph Rager's co-authors include Ismael J. Hidalgo, Jibin Li, Qing Wang, Qing Wang, Jibin Li, Albert J. Owen, Neha Bhagwat, Peggy Scherle, Mizue Terai and Bruce Ruggeri and has published in prestigious journals such as Cancer Research, International Journal of Pharmaceutics and Investigative Ophthalmology & Visual Science.

In The Last Decade

Joseph Rager

9 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph Rager United States	5	138	124	50	45	44	9	339
Éva Hellinger Hungary	6	160 1.2×	92 0.7×	53 1.1×	143 3.2×	28 0.6×	9	400
Anne Mannila Finland	7	109 0.8×	142 1.1×	62 1.2×	20 0.4×	38 0.9×	8	326
Madhu Sudhana Saddala United States	15	62 0.4×	191 1.5×	17 0.3×	80 1.8×	30 0.7×	42	515
William Neway United States	11	203 1.5×	264 2.1×	27 0.5×	16 0.4×	31 0.7×	14	557
Kazunobu Aoyama Japan	14	83 0.6×	199 1.6×	73 1.5×	10 0.2×	72 1.6×	19	409
Kathryn Ball France	10	211 1.5×	85 0.7×	30 0.6×	12 0.3×	51 1.2×	15	407
Junhao Li China	11	96 0.7×	89 0.7×	31 0.6×	24 0.5×	22 0.5×	33	349
David M. Bender United States	10	80 0.6×	195 1.6×	72 1.4×	9 0.2×	63 1.4×	14	429
Eric Y. Zhang United States	9	187 1.4×	127 1.0×	10 0.2×	15 0.3×	37 0.8×	11	425
Shane Roller United States	12	39 0.3×	143 1.2×	62 1.2×	8 0.2×	31 0.7×	24	359

Countries citing papers authored by Joseph Rager

Since Specialization

Citations

This map shows the geographic impact of Joseph Rager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Rager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Rager more than expected).

Fields of papers citing papers by Joseph Rager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Rager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Rager. The network helps show where Joseph Rager may publish in the future.

Co-authorship network of co-authors of Joseph Rager

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Rager. A scholar is included among the top collaborators of Joseph Rager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Rager. Joseph Rager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hulse, Michael, et al.. (2023). PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies. Cancer Research Communications. 3(11). 2233–2243. 15 indexed citations

Wang, Min, et al.. (2023). Abstract C013: Clinical biomarkers based on PK/PD modeling to guide the development for a first-in-class, highly selective SMARCA2 (BRM) degrader, PRT3789. Molecular Cancer Therapeutics. 22(12_Supplement). C013–C013. 1 indexed citations

Ito, Koichi, Joseph Rager, Neha Bhagwat, et al.. (2022). Abstract 2159: PRMT5 inhibitor PRT543 displays potent antitumor activity in U2AF1S34F and RBM10LOF spliceosome-mutant non-small cell lung cancer in vitro and in vivo. Cancer Research. 82(12_Supplement). 2159–2159. 3 indexed citations

Ito, Koichi, Neha Bhagwat, Joseph Rager, et al.. (2021). Abstract 1137: PRMT5 inhibition regulates alternative splicing and DNA damage repair pathways in SF3B1 R625G expressing uveal melanoma cells. Cancer Research. 81(13_Supplement). 1137–1137. 7 indexed citations

Ito, Koichi, Neha Bhagwat, Joseph Rager, et al.. (2021). Abstract 1138: PRMT5 inhibition downregulates MYB and NOTCH1 signaling, key molecular drivers of adenoid cystic carcinoma. Cancer Research. 81(13_Supplement). 1138–1138. 5 indexed citations

Wayne, Nancy L., et al.. (2018). Exposure assessment of laboratory workers to hazardous waste from mice treated with tamoxifen and bromodeoxyuridine. ACS Chemical Health & Safety. 26(1). 2–8. 1 indexed citations

Rager, Joseph, et al.. (2012). In Vitro Hydrolysis of Latanoprost by Human Ocular Tissues. Investigative Ophthalmology & Visual Science. 53(14). 5319–5319. 2 indexed citations

Wang, Qing, et al.. (2004). Evaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrier. International Journal of Pharmaceutics. 288(2). 349–359. 275 indexed citations

Rager, Joseph, et al.. (2003). CRYOPRESERVED HUMAN HEPATOCYTES AS ALTERNATIVE IN VITRO MODEL FOR CYTOCHROME P450 INDUCTION STUDIES. In Vitro Cellular & Developmental Biology - Animal. 39(7). 283–283. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact